Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study

BACKGROUND: Protease inhibitor monotherapy is associated with more frequent episodes of viral rebounds above 50 copies/mL than triple therapy. Objective: To evaluate if, compared to triple-drug therapy, protease inhibitor monotherapy is associated with increased levels of inflammatory/procoagulant m...

Descripción completa

Detalles Bibliográficos
Autores principales: Estébanez, Miriam, Stella-Ascariz, Natalia, Mingorance, Jesús, Pérez-Valero, Ignacio, Bernardino, Jose Ignacio, Zamora, Francisco Xavier, Montes, Maria Luisa, González-García, Juan Julián, Arribas, José Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097047/
https://www.ncbi.nlm.nih.gov/pubmed/25015544
http://dx.doi.org/10.1186/1471-2334-14-379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097047/
https://www.ncbi.nlm.nih.gov/pubmed/25015544
http://dx.doi.org/10.1186/1471-2334-14-379

Ejemplares similares